Breaking News

Polyplus, Merck Sign License and Supply Pact

Polyplus to supply PEI-based transfection reagents

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Polyplus-transfection SA and Merck have entered a license agreement and extended supply agreement for Polyplus-transfection’s polyethylenimine (PEI) based transfection reagents. Financial terms were not disclosed. Polyplus-transfection will supply Merck sites worldwide with batches of high quality linear PEI transfection reagent. The reagent, formulated and subject to appropriate quality controls, helps ensure safe and reproducible protein production in medium to large scale. Merck also gains r...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters